| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/17/2009 | US20090312522 Synthetic active peptide fragments |
| 12/17/2009 | US20090312410 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof |
| 12/17/2009 | US20090312403 Compositions and methods for wt1 specific immunotherapy |
| 12/17/2009 | US20090312298 Methods and Compositions Related to GABA Receptor Subunits |
| 12/17/2009 | US20090312265 Novel antimicrobial peptides and use thereof |
| 12/17/2009 | US20090312263 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides |
| 12/17/2009 | US20090312262 Peptide compound with biological activity, its preparation and its applications |
| 12/17/2009 | US20090312260 Drug therapy for celiac sprue |
| 12/17/2009 | US20090312259 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| 12/17/2009 | US20090312258 Uses of human zven proteins and polynucleotides |
| 12/17/2009 | US20090312257 Uses of human zven proteins and polynucleotides |
| 12/17/2009 | US20090312256 Uses of human zven proteins and polynucleotides |
| 12/17/2009 | US20090312254 Long-acting polypeptides and methods of producing same |
| 12/17/2009 | US20090312253 Methods of effecting Wnt signaling through Dkk structural analysis |
| 12/17/2009 | US20090312249 TLR4 decoy receptor protein |
| 12/17/2009 | US20090312248 Antimicrobial protein |
| 12/17/2009 | US20090312247 Natriuretic peptide related fragment in cardiovascular disease |
| 12/17/2009 | US20090312245 SRA binding protein |
| 12/17/2009 | US20090312244 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 12/17/2009 | US20090312236 Pegylated insulin lispro compounds |
| 12/17/2009 | US20090312185 Epsp synthase highly tolerant of glyphosate |
| 12/17/2009 | US20090311802 Isolated Soluble IL-TIF/IL-22 Receptor or Binding Protein Which Binds to IL-TIF/IL-22 and Uses Thereof |
| 12/17/2009 | US20090311792 Fibroblast growth factor (FGF23) and methods for use |
| 12/17/2009 | US20090311789 Method for preparing differentiated avian cells and genes involved in maintaining pluripotency |
| 12/17/2009 | US20090311783 Insulin-like growth factor-i receptor antagonists |
| 12/17/2009 | US20090311748 Heart20049410 polypeptides and methods of making the same |
| 12/17/2009 | US20090311746 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 12/17/2009 | US20090311727 Recombinant deamidated gliadin antigen |
| 12/17/2009 | US20090311722 Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines |
| 12/17/2009 | US20090311711 CRH and POMC Effects on Animal Growth |
| 12/17/2009 | US20090311696 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 12/17/2009 | US20090311674 Phosphate Biosensors and Methods of Using the Same |
| 12/17/2009 | US20090311671 Diagnosis of risk of breast cancer |
| 12/17/2009 | US20090311398 Isolated polypeptides and polynucleotides encoding same for generating plants with increased cuticlar water permeability |
| 12/17/2009 | US20090311326 Pulmonary Insulin Crystals |
| 12/17/2009 | US20090311313 Methods for treating tweak-related conditions |
| 12/17/2009 | US20090311287 Novel flavivirus antigens |
| 12/17/2009 | US20090311284 Recombinant Viral Proteins And Particles |
| 12/17/2009 | US20090311282 Neutralizing gdf8 epitope-based growth enhancing vaccine |
| 12/17/2009 | US20090311281 Novel method for down-regulation of amyloid |
| 12/17/2009 | US20090311280 Novel tnf receptor regulatory domain |
| 12/17/2009 | US20090311279 Colorectal Cancer Antigen |
| 12/17/2009 | US20090311278 Novel teleost derived antimicrobial polypeptides |
| 12/17/2009 | US20090311276 Nanolipoprotein particles and related compositions, methods and systems |
| 12/17/2009 | US20090311275 Carrier for targeting nerve cells |
| 12/17/2009 | US20090311274 Polynucleotide coding tumor protein for use as preventive, diagnostic and prognostic tool in treatment of cell proliferative disorders |
| 12/17/2009 | US20090311263 Human vascular ibp-like growth factor |
| 12/17/2009 | US20090311262 Method for Diagnosing Cancers Expressing the HER2 Receptor or its Truncated Variants |
| 12/17/2009 | US20090311261 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 12/17/2009 | US20090311260 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 12/17/2009 | US20090311256 12 Human Secreted Proteins |
| 12/17/2009 | US20090311247 Molecules and chimeric molecules thereof |
| 12/17/2009 | US20090311241 Human antibodies that bind human IL-12 and methods for producing |
| 12/17/2009 | US20090311225 Compositions of and Methods of Using Stabilized PSMA Dimers |
| 12/17/2009 | US20090311224 Therapeutic agent comprising lipocalin 2 against cancer metastasis, and methods of early diagnosis and inhibition of cancer metastasis using lipocalin 2 |
| 12/17/2009 | US20090311221 Biomaterials for regenerative medicine |
| 12/17/2009 | US20090311218 Novel mutant interferon-alpha protein, particularly interferon-alpha subtype alpha 8; provides agents for susceptive diseases superior in anti-viral and anti-tumor actions compared with conventional agents for susceptive diseases; agents against tumors, viral diseases, and infection diseases |
| 12/17/2009 | US20090311216 Recombinant interferon-beta with enhanced biological activity |
| 12/17/2009 | US20090311185 Peptide having antianxiety activity and screening method therefor |
| 12/17/2009 | DE10315030B4 Zyklische Peptide, Verfahren zu deren Herstellung und deren medizinische Verwendung Cyclic peptides, process for their preparation and to their medical use |
| 12/17/2009 | CA2727898A1 Novel antiviral peptides against influenza virus |
| 12/17/2009 | CA2727811A1 Conjugates for the administration of biologically active compounds |
| 12/17/2009 | CA2727657A1 Anti-angiogenic compositions and therapeutic applications thereof |
| 12/17/2009 | CA2727627A1 Use of histamine h4 antagonist for the treatment of post-operative adhesions |
| 12/17/2009 | CA2727625A1 Solutions for tissue engineering and methods of use |
| 12/17/2009 | CA2727614A1 Novel bacillus thuringiensis gene with lepidopteran activity |
| 12/17/2009 | CA2727613A1 Novel bacillus thuringiensis gene with lepidopteran activity |
| 12/17/2009 | CA2727485A1 Iqgap3 epitope peptides and vaccines containing the same |
| 12/17/2009 | CA2727341A1 Novel bmp-12-related proteins and methods of their manufacture |
| 12/17/2009 | CA2727141A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 12/17/2009 | CA2727086A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
| 12/17/2009 | CA2727082A1 Suppression of neuroendocrine diseases |
| 12/17/2009 | CA2727010A1 Methods for improving viability and productivity in cell culture |
| 12/17/2009 | CA2726768A1 Methods and compositions for generation of bax- and bak-deficient cell lines |
| 12/17/2009 | CA2726092A1 Suppression of cancers |
| 12/17/2009 | CA2726076A1 Peptide analogs of alpha-melanocyte stimulating hormone |
| 12/16/2009 | EP2133427A1 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 12/16/2009 | EP2133426A2 Compositions and methods for the modification of gene transcription |
| 12/16/2009 | EP2133424A1 Peptide transporting to chromoplasts in petals and method of constructing plant having yellowish petals by using the same |
| 12/16/2009 | EP2133423A1 Germ cell marker using fish vasa gene |
| 12/16/2009 | EP2133416A1 Recombinant microorganism |
| 12/16/2009 | EP2133364A1 Block Co-Polypeptide and hydrogels made thereof |
| 12/16/2009 | EP2133362A1 Antagonists and agonists of LDCAM and methods of use |
| 12/16/2009 | EP2133360A2 Environmental stress tolerance genes |
| 12/16/2009 | EP2133359A2 Recombinant haemophilus influenzae adhesin proteins |
| 12/16/2009 | EP2133358A1 Rift valley fever virus-like particles and their use for immunization and as test system |
| 12/16/2009 | EP2133100A1 MTB32A Antigen of mycobacterium tuberculosis with inactivated active site and fusion proteins thereof |
| 12/16/2009 | EP2133098A1 G-CSF conjugates |
| 12/16/2009 | EP2132984A2 Interferon-like protein ZCYTO21 |
| 12/16/2009 | EP2132568A1 Method of determining risk of scoliosis |
| 12/16/2009 | EP2132326A2 Methods |
| 12/16/2009 | EP2132319A1 Method for producing an antifungal peptide in a filamentous fungal host cell |
| 12/16/2009 | EP2132318A2 Compositions and methods for reducing h2s levels in fermented beverages |
| 12/16/2009 | EP2132315A1 Reoviruses having modified sequences |
| 12/16/2009 | EP2132314A2 Variant activin receptor polypeptides and uses thereof |
| 12/16/2009 | EP2132225A1 Combined use of cell permeable nanog and oct4 for increasing self-renewal and suppressing differentiation of stem cells |
| 12/16/2009 | EP2132224A1 Cyclic receptor-associated protein (rap) peptides |
| 12/16/2009 | EP2132223A1 NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS |
| 12/16/2009 | EP2132222A1 Anti diabetic protein |
| 12/16/2009 | EP2132218A1 Transferases, epimerases, polynucleotides encoding these and uses thereof |